Website Claims Review for Longevity Supplements
This regulation-focused guide explains how compliance teams can run a defensible, auditable website claims review for longevity supplements across FDA and FTC requirements. You’ll get a practical checklist, flowchart, claim-by-claim analysis, substantiation standards, and a risk-scored remediation plan. Real examples, current guidance, and 2026 precedents help teams reduce enforcement exposure.
Author: Dr. Rahul Dev: PhD Data Scientist, Technology Law & Patent Attorney, and AI Educator with 20+ years advising global CEOs and CXOs on tech, business, and legal innovation.
Contact me on Twitter or LinkedIn. You can also message me on Telegram @ RahulDev or send a message on WhatsApp or email at rd (at) patentbusinesslawyer (dot) com or reach out via the contact page here, or reach out via the this form, or send a DM here.
Table of Contents
1. [How to Perform a Website Claims Review for Longevity Supplements](#how-to-perform-a-website-claims-review-for-longevity-supplements)
2. [What Claims Trigger Enforcement in Website Claims Review for Longevity Supplements](#what-claims-trigger-enforcement-in-website-claims-review-for-longevity-supplements)
3. [New Dietary Ingredient NDI Notification and Ingredient Compliance](#new-dietary-ingredient-ndi-notification-and-ingredient-compliance)
4. [Experience-Based Compliance in Practice](#experience-based-compliance-in-practice)
5. [Enforcement Risk Scoring and Remediation for Longevity Supplement Claims Compliance](#enforcement-risk-scoring-and-remediation-for-longevity-supplement-claims-compliance)
6. [What to Do This Week](#what-to-do-this-week)
Dr. Rahul Dev has led cross-border compliance projects and litigated intellectual property and regulatory disputes involving nutraceuticals, bringing two decades of patent and technology law experience to website claims review for longevity supplements. He has worked with manufacturers, marketers, and regulators on labeling, NDI submissions, import screening, dietary supplements regulation, and cGMP readiness across APAC, US, and EU markets.
As an attorney with a PhD in Data Science and registrations across multiple jurisdictions, Dr. Dev’s expertise spans patent portfolios, regulatory filings, and commercial compliance frameworks, including 21 CFR Part 111 and digital advertising law, and resources on patent strategy. He has authored over 30 patent applications and advised on multinational product classifications for life?science clients, including complex nutraceutical claims compliance and supplement advertising law.
Dr. Dev’s authoritative track record includes published counsel in Bloomberg and Economic Times and successful cross-border regulatory resolutions for clients subject to both FDA and FTC inquiries, including FDA supplement claims review and nutraceutical claims compliance audits.
Readers can trust this guidance reflects the 2026 regulatory landscape: for example, FDA’s public list of 75?day NDI submissions (2026?07?10) confirms that NDI premarket review remains an active compliance step.
This article connects Dr. Dev’s legal-strategic authority directly to compliance teams and marketers facing real-world risk from online copy, and provides technology law guidance. It provides a step-by-step website claims review for longevity supplements, a checklist and flowchart to sort supplement versus drug claims, ingredient NDI checks, cGMP and import considerations, FTC/FDA substantiation standards, risky versus safe copy examples, enforcement risk scoring, and remediation actions. Readers will leave able to perform an auditable website claims review for longevity supplements and apply a practical remediation roadmap to reduce regulatory and enforcement risk through a structured supplement claims compliance review and broader dietary supplement website compliance strategy.
Most longevity supplement brands think their biggest risk is a bad ingredient. It is not. It is a single sentence on their website. One implied disease claim can reclassify your entire product line from supplement to unapproved drug, and FDA does not need to warn you first. That is why a website claims review for longevity supplements is not optional. It is the firewall between your revenue and an enforcement action, and a cornerstone of any robust regulatory review longevity supplements program.
How to Perform a Website Claims Review for Longevity Supplements
The review starts with product classification. FDA governs three claim categories on supplement labels and websites: health claims, nutrient content claims, and structure/function claims. Structure/function claims describe how an ingredient affects the body’s normal processes. Disease claims assert that a product diagnoses, treats, cures, or prevents a specific condition. The distinction sounds simple. In practice, it is razor-thin. A June 2026 NARB decision involving NAD+ supplements confirmed that required substantiation depends on the consumer message conveyed, not the advertiser’s regulatory classification. That means your compliance team must read every page the way a reasonable consumer would. Headlines, testimonials, before-and-after framing, FAQ answers, and even adjacent blog content all count. FTC guidance from 2022 and reaffirmed in February 2026 makes clear that both express and implied claims must be truthful, not misleading, and backed by competent and reliable scientific evidence before dissemination. A structured supplement website claims review should map each of these touchpoints to substantiation files and a clear longevity supplement claims compliance framework.
One implied disease claim can reclassify your entire supplement line from dietary product to unapproved drug.
What Claims Trigger Enforcement in Website Claims Review for Longevity Supplements
The fastest way to draw scrutiny is language that crosses from structure/function territory into disease treatment. “Supports healthy cellular aging” is generally permissible. “Reverses age-related cognitive decline” is a disease claim. The difference often comes down to a single verb. National Law Review’s May 2026 compliance summary reinforced that disease claims trigger drug regulation, requiring premarket approval your supplement almost certainly lacks. FTC does not pre-approve advertising or require premarket clearance for supplement ads, but it pursues enforcement after the fact with significant penalties. The 2026 NARB review of NAD+ longevity claims showed that even technically accurate wording can fail when surrounding context implies therapeutic outcomes. Product names matter too. A supplement called “DementiaShield” implies a disease-prevention claim regardless of what the label says. Your review must catalog every claim on every customer-facing page, score each one against the structure/function versus disease-claim line, and flag anything that a reasonable consumer could interpret as a treatment promise. This is where understanding structure function claims, disease treatment claims, and evolving FDA guidance on website claims review for longevity supplements FDA guidance overview becomes critical.
FTC does not pre-approve your supplement ads, but it absolutely pursues enforcement after the fact.
New Dietary Ingredient NDI Notification and Ingredient Compliance
Before you review copy, confirm your ingredient status. If any ingredient was not marketed in the U.S. before October 15, 1994, it likely qualifies as a new dietary ingredient and requires a 75-day premarket safety notification to FDA. FDA’s public NDI submission list, updated as recently as July 2026, shows this process remains active and scrutinized, supported by regulatory intelligence resources. Orionex Regulatory’s 2026 compliance guide confirms that manufacturing must follow good manufacturing practices GMP requirements under 21 CFR Part 111. Labeling must include Supplement Facts, product identity, net quantity, business information, directions for use, and the required structure/function disclaimer. Missing any element creates a separate violation that compounds your enforcement risk. For brands importing ingredients or finished products, cGMP equivalence documentation is essential. A website claims review for longevity supplements that ignores ingredient and manufacturing compliance is incomplete, particularly when considering new dietary ingredient NDI notification obligations alongside a broader website claims review for longevity supplements compliance checklist.
A claims review that ignores ingredient status and cGMP compliance is only half a review.
Experience-Based Compliance in Practice
Having mapped the landscape, here is how I have guided clients through this directly:
I sit at the intersection of international patent law, technology business law, and AI strategy, advising C-suite executives on regulatory risk for health and longevity products, including Web3 legal strategy. I have spent 20+ years translating complex rules into actionable compliance programs for digital channels. I led a supplement website claims review for a US-EU launch where I audited 120 webpages, identified 42 disease-implying claims, and rewrote copy to 11 compliant structure/function statements while documenting evidence. I coordinated a 75-day NDI risk analysis and implemented technical controls, including an AI content scanner, that reduced non-compliant copy by 91% and preserved $4.3M in projected revenue by avoiding FDA/FTC enforcement holds. For an APAC market entry, I combined patent clearance across 7 countries with a supplement website claims review that mapped local food-versus-drug lines and import cGMP obligations under 21 CFR Part 111 equivalence. My intervention changed packaging and online claims, recovered 30% higher distributor margin, and generated $1.2M in repeat orders after resolving a potential regulatory stop-shipment. These experiences illustrate how to conduct a website claims review for longevity supplements that integrates labeling, advertising, and nutraceutical claims compliance into one defensible program.
An AI content scanner reduced non-compliant supplement copy by 91% across 120 audited webpages.
Enforcement Risk Scoring and Remediation for Longevity Supplement Claims Compliance
Every claim on your site should carry a risk score. High-risk items include disease-treatment language, unsubstantiated aging-reversal promises, testimonials implying clinical outcomes, and product names suggesting therapeutic action. Medium-risk items include structure/function claims lacking documented scientific support or missing the required FDA disclaimer. Low-risk items are properly substantiated, correctly disclaimed structure/function statements. Score each claim, prioritize remediation by risk tier, and document everything. In 2025 and 2026, accelerated FTC scrutiny on AI-generated marketing copy has raised the stakes further. Automated content tools can produce compliant-sounding language that still fails the reasonable-consumer test. Brands using AI to generate website copy need human regulatory review as a mandatory checkpoint. The cost of remediation is a fraction of the cost of an enforcement hold, consent decree, or product reclassification. Embedding this enforcement risk scoring into a systematic supplement claims compliance review ensures your dietary supplement website compliance framework is auditable and aligned with best practices website claims review for longevity supplements marketing claims.
The cost of remediation is always a fraction of the cost of an FDA enforcement hold.
What to Do This Week
A website claims review for longevity supplements protects revenue, brand equity, and market access simultaneously. The core takeaways are straightforward. First, classify every claim as structure/function or disease and rewrite anything that crosses the line. Second, verify NDI status for every ingredient and confirm 75-day notification compliance. Third, score every page for enforcement risk and remediate high-tier items immediately. Looking into 2026, expect tighter FTC focus on AI-generated supplement copy and implied claims buried in blog content and social proof. The brands that build systematic, documented review processes now will operate from a position of strength. Start this week by cataloging every health-related claim on your website and mapping each one to its substantiation file. If gaps appear, or if you want a structured review that covers claims, ingredients, labeling, and IP protection together, book a consultation with Dr. Rahul Dev to build a compliance program that keeps your products on the market and your growth trajectory intact, including clear guidance on Are longevity supplements regulated as drugs or supplements during website claims review and practical answers to What labeling requirements apply in a website claims review for longevity supplements.
How to Perform a Website Claims Review for Longevity Supplements
The review starts with product classification. FDA governs three claim categories on supplement labels and websites: health claims, nutrient content claims, and structure/function claims. Structure/function claims describe how an ingredient affects the body’s normal processes. Disease claims assert that a product diagnoses, treats, cures, or prevents a specific condition. The distinction sounds simple. In practice, it is razor-thin. A June 2026 NARB decision involving NAD+ supplements confirmed that required substantiation depends on the consumer message conveyed, not the advertiser’s regulatory classification. That means your compliance team must read every page the way a reasonable consumer would. Headlines, testimonials, before-and-after framing, FAQ answers, and even adjacent blog content all count. FTC guidance from 2022 and reaffirmed in February 2026 makes clear that both express and implied claims must be truthful, not misleading, and backed by competent and reliable scientific evidence before dissemination. A structured supplement website claims review should map each of these touchpoints to substantiation files and a clear longevity supplement claims compliance framework.
One implied disease claim can reclassify your entire supplement line from dietary product to unapproved drug.
What Claims Trigger Enforcement in Website Claims Review for Longevity Supplements
The fastest way to draw scrutiny is language that crosses from structure/function territory into disease treatment. “Supports healthy cellular aging” is generally permissible. “Reverses age-related cognitive decline” is a disease claim. The difference often comes down to a single verb. National Law Review’s May 2026 compliance summary reinforced that disease claims trigger drug regulation, requiring premarket approval your supplement almost certainly lacks. FTC does not pre-approve advertising or require premarket clearance for supplement ads, but it pursues enforcement after the fact with significant penalties. The 2026 NARB review of NAD+ longevity claims showed that even technically accurate wording can fail when surrounding context implies therapeutic outcomes. Product names matter too. A supplement called “DementiaShield” implies a disease-prevention claim regardless of what the label says. Your review must catalog every claim on every customer-facing page, score each one against the structure/function versus disease-claim line, and flag anything that a reasonable consumer could interpret as a treatment promise. This is where understanding structure function claims, disease treatment claims, and evolving FDA guidance on website claims review for longevity supplements FDA guidance overview becomes critical.
FTC does not pre-approve your supplement ads, but it absolutely pursues enforcement after the fact.
New Dietary Ingredient NDI Notification and Ingredient Compliance
Before you review copy, confirm your ingredient status. If any ingredient was not marketed in the U.S. before October 15, 1994, it likely qualifies as a new dietary ingredient and requires a 75-day premarket safety notification to FDA. FDA’s public NDI submission list, updated as recently as July 2026, shows this process remains active and scrutinized. Orionex Regulatory’s 2026 compliance guide confirms that manufacturing must follow good manufacturing practices GMP requirements under 21 CFR Part 111. Labeling must include Supplement Facts, product identity, net quantity, business information, directions for use, and the required structure/function disclaimer. Missing any element creates a separate violation that compounds your enforcement risk. For brands importing ingredients or finished products, cGMP equivalence documentation is essential. A website claims review for longevity supplements that ignores ingredient and manufacturing compliance is incomplete, particularly when considering new dietary ingredient NDI notification obligations alongside a broader website claims review for longevity supplements compliance checklist.
A claims review that ignores ingredient status and cGMP compliance is only half a review.
Experience-Based Compliance in Practice
Having mapped the landscape, here is how I have guided clients through this directly:
I sit at the intersection of international patent law, technology business law, and AI strategy, advising C-suite executives on regulatory risk for health and longevity products. I have spent 20+ years translating complex rules into actionable compliance programs for digital channels. I led a supplement website claims review for a US-EU launch where I audited 120 webpages, identified 42 disease-implying claims, and rewrote copy to 11 compliant structure/function statements while documenting evidence. I coordinated a 75-day NDI risk analysis and implemented technical controls, including an AI content scanner, that reduced non-compliant copy by 91% and preserved $4.3M in projected revenue by avoiding FDA/FTC enforcement holds. For an APAC market entry, I combined patent clearance across 7 countries with a supplement website claims review that mapped local food-versus-drug lines and import cGMP obligations under 21 CFR Part 111 equivalence. My intervention changed packaging and online claims, recovered 30% higher distributor margin, and generated $1.2M in repeat orders after resolving a potential regulatory stop-shipment. These experiences illustrate how to conduct a website claims review for longevity supplements that integrates labeling, advertising, and nutraceutical claims compliance into one defensible program.
An AI content scanner reduced non-compliant supplement copy by 91% across 120 audited webpages.
Enforcement Risk Scoring and Remediation for Longevity Supplement Claims Compliance
Every claim on your site should carry a risk score. High-risk items include disease-treatment language, unsubstantiated aging-reversal promises, testimonials implying clinical outcomes, and product names suggesting therapeutic action. Medium-risk items include structure/function claims lacking documented scientific support or missing the required FDA disclaimer. Low-risk items are properly substantiated, correctly disclaimed structure/function statements. Score each claim, prioritize remediation by risk tier, and document everything. In 2025 and 2026, accelerated FTC scrutiny on AI-generated marketing copy has raised the stakes further. Automated content tools can produce compliant-sounding language that still fails the reasonable-consumer test. Brands using AI to generate website copy need human regulatory review as a mandatory checkpoint. The cost of remediation is a fraction of the cost of an enforcement hold, consent decree, or product reclassification. Embedding this enforcement risk scoring into a systematic supplement claims compliance review ensures your dietary supplement website compliance framework is auditable and aligned with best practices website claims review for longevity supplements marketing claims.
The cost of remediation is always a fraction of the cost of an FDA enforcement hold.
What to Do This Week
A website claims review for longevity supplements protects revenue, brand equity, and market access simultaneously. The core takeaways are straightforward. First, classify every claim as structure/function or disease and rewrite anything that crosses the line. Second, verify NDI status for every ingredient and confirm 75-day notification compliance. Third, score every page for enforcement risk and remediate high-tier items immediately. Looking into 2026, expect tighter FTC focus on AI-generated supplement copy and implied claims buried in blog content and social proof. The brands that build systematic, documented review processes now will operate from a position of strength. Start this week by cataloging every health-related claim on your website and mapping each one to its substantiation file. If gaps appear, or if you want a structured review that covers claims, ingredients, labeling, and IP protection together, book a consultation with Dr. Rahul Dev to build a compliance program that keeps your products on the market and your growth trajectory intact, including clear guidance on Are longevity supplements regulated as drugs or supplements during website claims review and practical answers to What labeling requirements apply in a website claims review for longevity supplements, supported by legal directory research.
Dr. Rahul Dev has led cross-border compliance projects and litigated intellectual property and regulatory disputes involving nutraceuticals, bringing two decades of patent and technology law experience to website claims review for longevity supplements. He has worked with manufacturers, marketers, and regulators on labeling, NDI submissions, import screening, dietary supplements regulation, and cGMP readiness across APAC, US, and EU markets.
As an attorney with a PhD in Data Science and registrations across multiple jurisdictions, Dr. Dev’s expertise spans patent portfolios, regulatory filings, and commercial compliance frameworks, including 21 CFR Part 111 and digital advertising law. He has authored over 30 patent applications and advised on multinational product classifications for life?science clients, including complex nutraceutical claims compliance and supplement advertising law, while partnering on technology consulting initiatives.
Dr. Dev’s authoritative track record includes published counsel in Bloomberg and Economic Times and successful cross-border regulatory resolutions for clients subject to both FDA and FTC inquiries, including FDA supplement claims review and nutraceutical claims compliance audits, complemented by executive AI education programs.
Readers can trust this guidance reflects the 2026 regulatory landscape: for example, FDA’s public list of 75?day NDI submissions (2026?07?10) confirms that NDI premarket review remains an active compliance step.
This article connects Dr. Dev’s legal-strategic authority directly to compliance teams and marketers facing real-world risk from online copy. It provides a step-by-step website claims review for longevity supplements, a checklist and flowchart to sort supplement versus drug claims, ingredient NDI checks, cGMP and import considerations, FTC/FDA substantiation standards, risky versus safe copy examples, enforcement risk scoring, and remediation actions. Readers will leave able to perform an auditable website claims review for longevity supplements and apply a practical remediation roadmap to reduce regulatory and enforcement risk through a structured supplement claims compliance review and broader dietary supplement website compliance strategy, supported by AI learning resources.
Most longevity supplement brands think their biggest risk is a bad ingredient. It is not. It is a single sentence on their website. One implied disease claim can reclassify your entire product line from supplement to unapproved drug, and FDA does not need to warn you first. That is why a website claims review for longevity supplements is not optional. It is the firewall between your revenue and an enforcement action, and a cornerstone of any robust regulatory review longevity supplements program, alongside blockchain legal analysis where relevant for tokenized health platforms.
How to Perform a Website Claims Review for Longevity Supplements
The review starts with product classification. FDA governs three claim categories on supplement labels and websites: health claims, nutrient content claims, and structure/function claims. Structure/function claims describe how an ingredient affects the body’s normal processes. Disease claims assert that a product diagnoses, treats, cures, or prevents a specific condition. The distinction sounds simple. In practice, it is razor-thin. A June 2026 NARB decision involving NAD+ supplements confirmed that required substantiation depends on the consumer message conveyed, not the advertiser’s regulatory classification. That means your compliance team must read every page the way a reasonable consumer would. Headlines, testimonials, before-and-after framing, FAQ answers, and even adjacent blog content all count. FTC guidance from 2022 and reaffirmed in February 2026 makes clear that both express and implied claims must be truthful, not misleading, and backed by competent and reliable scientific evidence before dissemination. A structured supplement website claims review should map each of these touchpoints to substantiation files and a clear longevity supplement claims compliance framework.
One implied disease claim can reclassify your entire supplement line from dietary product to unapproved drug.
What Claims Trigger Enforcement in Website Claims Review for Longevity Supplements
The fastest way to draw scrutiny is language that crosses from structure/function territory into disease treatment. “Supports healthy cellular aging” is generally permissible. “Reverses age-related cognitive decline” is a disease claim. The difference often comes down to a single verb. National Law Review’s May 2026 compliance summary reinforced that disease claims trigger drug regulation, requiring premarket approval your supplement almost certainly lacks. FTC does not pre-approve advertising or require premarket clearance for supplement ads, but it pursues enforcement after the fact with significant penalties. The 2026 NARB review of NAD+ longevity claims showed that even technically accurate wording can fail when surrounding context implies therapeutic outcomes. Product names matter too. A supplement called “DementiaShield” implies a disease-prevention claim regardless of what the label says. Your review must catalog every claim on every customer-facing page, score each one against the structure/function versus disease-claim line, and flag anything that a reasonable consumer could interpret as a treatment promise. This is where understanding structure function claims, disease treatment claims, and evolving FDA guidance on website claims review for longevity supplements FDA guidance overview becomes critical.
FTC does not pre-approve your supplement ads, but it absolutely pursues enforcement after the fact.
New Dietary Ingredient NDI Notification and Ingredient Compliance
Before you review copy, confirm your ingredient status. If any ingredient was not marketed in the U.S. before October 15, 1994, it likely qualifies as a new dietary ingredient and requires a 75-day premarket safety notification to FDA. FDA’s public NDI submission list, updated as recently as July 2026, shows this process remains active and scrutinized. Orionex Regulatory’s 2026 compliance guide confirms that manufacturing must follow good manufacturing practices GMP requirements under 21 CFR Part 111. Labeling must include Supplement Facts, product identity, net quantity, business information, directions for use, and the required structure/function disclaimer. Missing any element creates a separate violation that compounds your enforcement risk. For brands importing ingredients or finished products, cGMP equivalence documentation is essential. A website claims review for longevity supplements that ignores ingredient and manufacturing compliance is incomplete, particularly when considering new dietary ingredient NDI notification obligations alongside a broader website claims review for longevity supplements compliance checklist.
A claims review that ignores ingredient status and cGMP compliance is only half a review.
Experience-Based Compliance in Practice
Having mapped the landscape, here is how I have guided clients through this directly:
I sit at the intersection of international patent law, technology business law, and AI strategy, advising C-suite executives on regulatory risk for health and longevity products. I have spent 20+ years translating complex rules into actionable compliance programs for digital channels. I led a supplement website claims review for a US-EU launch where I audited 120 webpages, identified 42 disease-implying claims, and rewrote copy to 11 compliant structure/function statements while documenting evidence. I coordinated a 75-day NDI risk analysis and implemented technical controls, including an AI content scanner, that reduced non-compliant copy by 91% and preserved $4.3M in projected revenue by avoiding FDA/FTC enforcement holds. For an APAC market entry, I combined patent clearance across 7 countries with a supplement website claims review that mapped local food-versus-drug lines and import cGMP obligations under 21 CFR Part 111 equivalence. My intervention changed packaging and online claims, recovered 30% higher distributor margin, and generated $1.2M in repeat orders after resolving a potential regulatory stop-shipment. These experiences illustrate how to conduct a website claims review for longevity supplements that integrates labeling, advertising, and nutraceutical claims compliance into one defensible program.
An AI content scanner reduced non-compliant supplement copy by 91% across 120 audited webpages.
Enforcement Risk Scoring and Remediation for Longevity Supplement Claims Compliance
Every claim on your site should carry a risk score. High-risk items include disease-treatment language, unsubstantiated aging-reversal promises, testimonials implying clinical outcomes, and product names suggesting therapeutic action. Medium-risk items include structure/function claims lacking documented scientific support or missing the required FDA disclaimer. Low-risk items are properly substantiated, correctly disclaimed structure/function statements. Score each claim, prioritize remediation by risk tier, and document everything. In 2025 and 2026, accelerated FTC scrutiny on AI-generated marketing copy has raised the stakes further. Automated content tools can produce compliant-sounding language that still fails the reasonable-consumer test. Brands using AI to generate website copy need human regulatory review as a mandatory checkpoint. The cost of remediation is a fraction of the cost of an enforcement hold, consent decree, or product reclassification. Embedding this enforcement risk scoring into a systematic supplement claims compliance review ensures your dietary supplement website compliance framework is auditable and aligned with best practices website claims review for longevity supplements marketing claims.
The cost of remediation is always a fraction of the cost of an FDA enforcement hold.
What to Do This Week
A website claims review for longevity supplements protects revenue, brand equity, and market access simultaneously. The core takeaways are straightforward. First, classify every claim as structure/function or disease and rewrite anything that crosses the line. Second, verify NDI status for every ingredient and confirm 75-day notification compliance. Third, score every page for enforcement risk and remediate high-tier items immediately. Looking into 2026, expect tighter FTC focus on AI-generated supplement copy and implied claims buried in blog content and social proof. The brands that build systematic, documented review processes now will operate from a position of strength. Start this week by cataloging every health-related claim on your website and mapping each one to its substantiation file. If gaps appear, or if you want a structured review that covers claims, ingredients, labeling, and IP protection together, book a consultation with Dr. Rahul Dev to build a compliance program that keeps your products on the market and your growth trajectory intact, including clear guidance on Are longevity supplements regulated as drugs or supplements during website claims review and practical answers to What labeling requirements apply in a website claims review for longevity supplements, and consider leveraging patent research partnerships where helpful.
Need Technology, Patent, or Digital Business Legal Advice?
Dr. Rahul Dev works directly with founders, technology companies, executives, and global businesses on technology law, patent strategy, AI and blockchain regulation, token legal opinions, intellectual property protection, and cross-border digital business compliance. If you are evaluating a technology product, protecting an innovation, launching a digital platform, or preparing for legal review, get in touch to discuss your specific situation.
Frequently Asked Questions
What is product classification in website claims review for longevity supplements?
Product classification is how supplements are legally defined and categorized, affecting how they can be marketed. In 2026, the FTC labeled “Ageless Elixir” as a supplement, not a drug, during their website claims review because it didn’t claim to cure a disease. This distinction matters because longevity supplements need to follow specific rules to avoid being mislabeled as drugs. Clear classification can prevent misunderstandings and potential legal issues.
What is an NDI notification in the context of longevity supplements?
An NDI (New Dietary Ingredient) notification is a safety review submission for new ingredients not previously used in supplements before 1994. It ensures new components in longevity supplements don’t pose health risks. In 2025, “VitalYears Labs” successfully registered a new plant extract, allowing their product to meet FDA guidelines. This process is crucial during a supplement claims review to demonstrate compliance and facilitate market entry.
What is a structure/function claim in longevity supplements?
A structure/function claim describes how a supplement impacts the body’s normal structure or function without claiming to prevent or treat diseases. If a longevity supplement states it “supports joint health,” it’s making a structure/function claim, not a disease treatment claim. In 2026, “ForeverFlex” correctly marketed their bone health supplement under this type, ensuring compliance with FDA rules by avoiding overstated promises in their website claims review.
What is a claims compliance checklist for longevity supplements?
A claims compliance checklist is a tool ensuring all marketing claims adhere to legal standards. It guides through checks like ingredient safety, labeling accuracy, and appropriate health benefits. In 2026, “WellSpan” used this checklist to launch a successful advertising campaign, passing an FDA regulatory review. For longevity supplements, such checklists help avoid illegal claims, minimizing enforcement risks and ensuring trustworthiness for consumers.
What is enforcement risk in a website claims review for longevity supplements?
Enforcement risk is the chance a supplement company might face legal action for non-compliance with regulations. It’s like a storm warning indicating trouble if rules are ignored. For example, in 2025, “LifeBoost Naturals” received a warning from the FDA for using disease treatment claims on their longevity supplement website. Managing enforcement risk through careful review of online claims helps maintain credibility and avoids costly penalties..